what are the Recommendations for Treatment of Cardiac Amyloidosis
Referenced studies that support the recommendations are summa-
rized in the Online Data Supplements.?
In select patients with wild-type or variant trans- thyretin cardiac amyloidosis and NYHA class I to III HF symptoms, transthyretin tetramer sta- bilizer therapy (tafamidis) is indicated to reduce cardiovascular morbidity and mortality.